Kinaxis® Inc. ("Kinaxis" or the "Company") (TSX: KXS) today announces that, further to its previously announced intention to ...
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results